AgeX Therapeutics AGE
€ 10.80
-10.17%
Quartalsbericht 2024-Q3
hinzugefügt 12.11.2024
AgeX Therapeutics Bilanz 2011-2024 | AGE
Bilanz Jährlich AgeX Therapeutics
2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nettoverschuldung |
- | - | 12.6 M | - | -396 K | -6.71 M | -7.38 M | - | - | - | - | - | - |
Langfristige Schulden |
- | - | 13.2 M | - | 1.53 M | - | - | - | - | - | - | - | - |
Langfristiger Schuldenstrom |
- | - | - | - | 428 K | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | 1.53 M | - | - | - | - | - | - | - | - |
Kurzfristige Verbindlichkeiten |
5.91 M | 10.1 M | 8.97 M | 5.36 M | 3.3 M | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
6.61 M | 20.6 M | 15 M | 9.32 M | 4.82 M | 2.44 M | 1.31 M | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | 283 K | 317 K | 180 K | - | - | - | - | - | - |
Gewinnrücklagen |
-131 M | -116 M | -106 M | - | -86.2 M | -74.1 M | -66.6 M | - | - | - | - | - | - |
Vermögenswerte |
12 M | 3.24 M | 3.15 M | 3.92 M | 7.44 M | 10.7 M | 9.63 M | - | - | - | - | - | - |
Zahlungsmittel |
345 K | 645 K | 584 K | 527 K | 2.35 M | 6.71 M | 7.38 M | - | - | - | - | - | - |
Buchwert |
5.36 M | -17.3 M | -11.9 M | -5.4 M | 2.62 M | 8.23 M | 8.32 M | - | - | - | - | - | - |
Gesamtes Eigenkapital |
5.47 M | -17.2 M | -11.8 M | -5.4 M | 2.22 M | 7.45 M | 8.32 M | - | - | - | - | - | - |
Alle Zahlen in USD-Währung
Bilanz Vierteljährlich AgeX Therapeutics
2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q4 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Langfristige Schulden |
11.2 M | 362 K | 413 K | 1 K | - | - | - | - | 15.6 M | - | - | - | - | - | - | - | - | - | - | - | 142 K | 221 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Langfristige Verbindlichkeiten |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtverbindlichkeiten |
21.3 M | 27.1 M | 15.2 M | 4.86 M | 3.9 M | 34.6 M | 32.5 M | 20.6 M | 17.2 M | 15.8 M | 14.3 M | 15 M | 12.4 M | 10.8 M | 9.26 M | 9.32 M | 9.32 M | 9.32 M | 9.32 M | 4.82 M | 4.82 M | 4.82 M | 4.82 M | 2.44 M | 2.44 M | 2.44 M | 2.44 M | 1.31 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Aufgeschobenes Einkommen |
- | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 275 K | 275 K | 275 K | 275 K | 283 K | 283 K | 283 K | 283 K | 317 K | 317 K | 317 K | 317 K | 180 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gewinnrücklagen |
-21.8 M | -23.2 M | -5.44 M | -33.2 M | -128 M | -122 M | -119 M | -116 M | -114 M | -111 M | -108 M | -106 M | -104 M | -102 M | -99.2 M | -97.1 M | -97.1 M | -97.1 M | -97.1 M | -86.2 M | -86.2 M | -86.2 M | -86.2 M | -74.1 M | -74.1 M | -74.1 M | -74.1 M | -66.6 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Vermögenswerte |
7.44 M | 10.7 M | 10.9 M | 8.97 M | 12.2 M | 12.3 M | 12.5 M | 3.24 M | 2.01 M | 2.58 M | 2.72 M | 3.15 M | 2.43 M | 2.54 M | 3.16 M | 3.92 M | 3.92 M | 3.92 M | 3.92 M | 7.44 M | 7.44 M | 7.44 M | 7.44 M | 10.7 M | 10.7 M | 10.7 M | 10.7 M | 9.63 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Zahlungsmittel |
3.18 M | 6.06 M | 8.71 M | 7.62 M | 397 K | 261 K | 280 K | 645 K | 466 K | 702 K | 448 K | 584 K | 731 K | 615 K | 809 K | 527 K | 527 K | 527 K | 527 K | 2.35 M | 2.35 M | 2.35 M | 2.35 M | 6.71 M | 6.71 M | 6.71 M | 6.71 M | 7.38 M | - | - | - | 259 K | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Buchwert |
-13.8 M | -16.4 M | -4.31 M | 4.11 M | 8.31 M | -22.3 M | -20 M | -17.3 M | -15.1 M | -13.3 M | -11.6 M | -11.9 M | -9.98 M | -8.29 M | -6.1 M | -5.4 M | -5.4 M | -5.4 M | -5.4 M | 2.62 M | 2.62 M | 2.62 M | 2.62 M | 8.23 M | 8.23 M | 8.23 M | 8.23 M | 8.32 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Gesamtes Eigenkapital |
-13.8 M | -16.4 M | -4.31 M | -32.3 M | -33.3 M | -35.3 M | -36.1 M | -17.2 M | -15.1 M | -13.3 M | -11.6 M | -11.8 M | -9.98 M | -8.29 M | -6.06 M | -5.12 M | -5.12 M | -5.12 M | -5.12 M | 2.22 M | 2.22 M | 2.22 M | 2.22 M | 7.45 M | 7.45 M | 7.45 M | 7.45 M | 7.28 M | - | - | - | -22.4 M | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Alle Zahlen in USD-Währung